Raj Pruthi, MD, MHA, FACS

Title(s)Professor, Urology
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-353-7171
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin. Clin Cancer Res. 2021 Sep 15; 27(18):5123-5130. Chu CE, Sjöström M, Egusa EA, Gibb EA, Badura ML, Zhu J, Koshkin VS, Stohr BA, Meng MV, Pruthi RS, Friedlander TW, Lotan Y, Black PC, Porten SP, Feng FY, Chou J. PMID: 34108177.
      View in: PubMed   Mentions: 1     Fields:    
    2. Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo Clin Proc. 2021 07; 96(7):1718-1726. Chaudhary R, Padrnos L, Wysokinska E, Pruthi R, Misra S, Sridharan M, Wysokinski W, McBane RD, Houghton DE. PMID: 34218854.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    3. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer. 2021 05; 9(5). de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. PMID: 33980590.
      View in: PubMed   Mentions:    Fields:    
    4. Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment. Urology. 2021 Mar; 149:103-109. McMahon S, Basak R, Zhou X, Smith AB, Song L, Pruthi RS, Wallen EM, Nielsen ME, Tan HJ. PMID: 33352164.
      View in: PubMed   Mentions:    Fields:    
    5. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. PMID: 33278460.
      View in: PubMed   Mentions: 1     Fields:    
    6. Dedicated Residency Research Time and Its Relationship to Urologic Career Academic Success. Urology. 2021 Feb; 148:64-69. Lee A, Namiri N, Rios N, Enriquez A, Hampson LA, Pruthi RS, Breyer BN. PMID: 33166543.
      View in: PubMed   Mentions:    Fields:    
    7. Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis. J Med Internet Res. 2020 07 06; 22(7):e19322. Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY. PMID: 32568721.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsPHPublic Health
    8. Effect of COVID-19 on Urology Residency Training: A Nationwide Survey of Program Directors by the Society of Academic Urologists. J Urol. 2020 11; 204(5):1039-1045. Rosen GH, Murray KS, Greene KL, Pruthi RS, Richstone L, Mirza M. PMID: 32463716.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsPHPublic Health
    9. AUTHOR REPLY. Urology. 2020 May; 139:77. Gan ZS, Wood CM, Pruthi RS. PMID: 32418583.
      View in: PubMed   Mentions:    Fields:    
    10. Correlation of Relative Value Units With Surgical Complexity and Physician Workload in Urology. Urology. 2020 May; 139:71-77. Gan ZS, Wood CM, Hayon S, Deal A, Smith AB, Tan HJ, Pruthi RS. PMID: 32084413.
      View in: PubMed   Mentions:    Fields:    
    11. The Presence of Gender Bias in Letters of Recommendations Written for Urology Residency Applicants. Urology. 2019 12; 134:56-61. Filippou P, Mahajan S, Deal A, Wallen EM, Tan HJ, Pruthi RS, Smith AB. PMID: 31491451.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018 06 23; 391(10139):2525-2536. Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA, Thompson IM. PMID: 29976469.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    13. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review. Eur Urol Oncol. 2018 08; 1(3):223-230. Lotan Y, Black PC, Caba L, Chang SS, Cookson MS, Daneshmand S, Kamat AM, McKiernan JM, Pruthi RS, Ritch CR, Steinberg GD, Svatek RS, Zwarthoff EC. PMID: 31102625.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype. JCO Precis Oncol. 2017; 1. Kardos J, Wobker SE, Woods ME, Nielsen ME, Smith AB, Wallen EM, Pruthi RS, Hayward MC, McGinty KA, Grilley-Olson JE, Patel NM, Weck KE, Black P, Parker JS, Milowsky MI, Hayes DN, Kim WY. PMID: 32913973.
      View in: PubMed   Mentions: 2  
    15. The Expanding Role of Advanced Practice Providers in Urologic Procedural Care. Urology. 2017 08; 106:70-75. Langston JP, Duszak R, Orcutt VL, Schultz H, Hornberger B, Jenkins LC, Hemingway J, Hughes DR, Pruthi RS, Nielsen ME. PMID: 28435035.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Editorial Comment. Urology. 2017 06; 104:83. Pruthi RS, Filippou P. PMID: 28359533.
      View in: PubMed   Mentions:    Fields:    
    17. The Present and Future Challenges Facing Urology Departments at Academic Health Centers. Urology. 2017 Jun; 104:25-30. McCormick BJ, Pruthi RS. PMID: 28153591.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Projecting the Urology Workforce Over the Next 20 Years. Urology. 2016 Dec; 98:21-26. McKibben MJ, Kirby EW, Langston J, Raynor MC, Nielsen ME, Smith AB, Wallen EM, Woods ME, Pruthi RS, McKibben MJ, Kirby EW, Langston J, Raynor MC, Nielsen ME, Smith AB, Wallen EM, Woods ME, Pruthi RS. PMID: 27491965.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review. Eur Urol Focus. 2017 02; 3(1):136-143. Smith AB, Crowell K, Woods ME, Wallen EM, Pruthi RS, Nielsen ME, Lee CT. PMID: 28720359.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Enhanced Recovery after Urological Surgery: A Contemporary Systematic Review of Outcomes, Key Elements, and Research Needs. Eur Urol. 2016 07; 70(1):176-187. Azhar RA, Bochner B, Catto J, Goh AC, Kelly J, Patel HD, Pruthi RS, Thalmann GN, Desai M, Azhar RA, Bochner B, Catto J, Goh AC, Kelly J, Patel HD, Pruthi RS, Thalmann GN, Desai M. PMID: 26970912; PMCID: PMC5514421.
      View in: PubMed   Mentions: 49     Fields:    
    21. Radical Cystectomy Perioperative Care Redesign. Urology. 2015 Dec; 86(6):1076-86. Matulewicz RS, Brennan J, Pruthi RS, Kundu SD, Gonzalez CM, Meeks JJ, Matulewicz RS, Brennan J, Pruthi RS, Kundu SD, Gonzalez CM, Meeks JJ. PMID: 26383615.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    22. Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings. Urol Oncol. 2015 Sep; 33(9):386.e1-6. Rose TL, Deal AM, Basch E, Godley PA, Rathmell WK, Kim WY, Whang YE, Dunn MW, Wang A, Chen RC, Nielsen ME, Pruthi RS, Wallen EM, Woods ME, Smith AB, Milowsky MI, Rose TL, Deal AM, Basch E, Godley PA, Rathmell WK, Kim WY, Whang YE, Dunn MW, Wang A, Chen RC, Nielsen ME, Pruthi RS, Wallen EM, Woods ME, Smith AB, Milowsky MI. PMID: 26122712; PMCID: PMC5084688.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Nutritional predictors of complications following radical cystectomy. World J Urol. 2015 Aug; 33(8):1129-37. Johnson DC, Riggs SB, Nielsen ME, Matthews JE, Woods ME, Wallen EM, Pruthi RS, Smith AB, Johnson DC, Riggs SB, Nielsen ME, Matthews JE, Woods ME, Wallen EM, Pruthi RS, Smith AB. PMID: 25240535; PMCID: PMC5015441.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    24. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. J Urol. 2015 Feb; 193(2):436-42. Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP, Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. PMID: 25063493.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    25. Enhanced recovery programmes for patients undergoing radical cystectomy. Nat Rev Urol. 2014 Aug; 11(8):437-44. Smith J, Pruthi RS, McGrath J, Smith J, Pruthi RS, McGrath J. PMID: 25023593.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    26. Enhanced recovery programmes: an important step towards going lean in healthcare. BJU Int. 2014 May; 113(5):685-6. Pruthi RS, Raynor MC, Pruthi RS, Raynor MC. PMID: 24717058.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU Int. 2014 Nov; 114(5):719-26. Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI, Nielsen ME, Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI, Nielsen ME. PMID: 24325202.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    28. Postoperative ileus after radical cystectomy: looking for answers to an age-old problem. Eur Urol. 2014 Aug; 66(2):273-4. Raynor MC, Pruthi RS, Raynor MC, Pruthi RS. PMID: 24746972.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Metabolic syndrome as a predictor for postoperative complications after urologic surgery. Urology. 2014 May; 83(5):1051-9. Selph JP, Whited WM, Smith AB, Matthews J, Pruthi RS, Wallen EM, Nielsen ME, Woods ME, Selph JP, Whited WM, Smith AB, Matthews J, Pruthi RS, Wallen EM, Nielsen ME, Woods ME. PMID: 24656508.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Sarcopenia as a predictor of complications and survival following radical cystectomy. J Urol. 2014 Jun; 191(6):1714-20. Smith AB, Deal AM, Yu H, Boyd B, Matthews J, Wallen EM, Pruthi RS, Woods ME, Muss H, Nielsen ME, Smith AB, Deal AM, Yu H, Boyd B, Matthews J, Wallen EM, Pruthi RS, Woods ME, Muss H, Nielsen ME. PMID: 24423437.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    31. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer. 2014 Jan 01; 120(1):86-95. Nielsen ME, Smith AB, Meyer AM, Kuo TM, Tyree S, Kim WY, Milowsky MI, Pruthi RS, Millikan RC, Nielsen ME, Smith AB, Meyer AM, Kuo TM, Tyree S, Kim WY, Milowsky MI, Pruthi RS, Millikan RC. PMID: 24122346; PMCID: PMC3964001.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    32. Recent trends in the urology workforce in the United States. Urology. 2013 Nov; 82(5):987-93. Pruthi RS, Neuwahl S, Nielsen ME, Fraher E, Pruthi RS, Neuwahl S, Nielsen ME, Fraher E. PMID: 24055244.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    33. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol. 2014 Sep; 66(3):577-83. Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP, Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. PMID: 23871402.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    34. Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study. Cancer. 2013 Jan 15; 119(2):421-8. Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Mishel M, Pruthi RS, Mohler JL, Godley PA, Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Mishel M, Pruthi RS, Mohler JL, Godley PA. PMID: 22786794; PMCID: PMC7671233.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    35. Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years. Urol Oncol. 2013 Nov; 31(8):1621-7. Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys MR, Woods ME, Castle EP, Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys MR, Woods ME, Castle EP. PMID: 22534088.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    36. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey. BJU Int. 2012 Oct; 110(7):967-72. Nielsen ME, Smith AB, Pruthi RS, Guzzo TJ, Amiel G, Shore N, Lotan Y, Nielsen ME, Smith AB, Pruthi RS, Guzzo TJ, Amiel G, Shore N, Lotan Y. PMID: 22487336.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A. 2012 Jan-Feb; 22(1):17-21. Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen M, Thomas R, Wallen EM, Woods M, Pruthi RS, Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen M, Thomas R, Wallen EM, Woods M, Pruthi RS. PMID: 22142028.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    38. Carcinoma in a cadaveric transplant kidney. Urology. 2012 Apr; 79(4):758-60. Manvar AM, Rathmell WK, Ferguson J, Pruthi RS, Nielsen ME, Wallen EM, Nolan N, Raynor MC, Manvar AM, Rathmell WK, Ferguson J, Pruthi RS, Nielsen ME, Wallen EM, Nolan N, Raynor MC. PMID: 22014593.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Peri- and postoperative outcomes of robot-assisted radical cystectomy (RARC). BJU Int. 2011 Sep; 108(6 Pt 2):969-75. Smith AB, Raynor MC, Pruthi RS, Smith AB, Raynor MC, Pruthi RS. PMID: 21917099.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion. Urol Oncol. 2013 Jan; 31(1):32-5. Raynor MC, Lavien G, Nielsen M, Wallen EM, Pruthi RS, Raynor MC, Lavien G, Nielsen M, Wallen EM, Pruthi RS. PMID: 21719323.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. Feasibility and outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older patients. Urology. 2011 May; 77(5):1111-4. Coward RM, Smith A, Raynor M, Nielsen M, Wallen EM, Pruthi RS, Coward RM, Smith A, Raynor M, Nielsen M, Wallen EM, Pruthi RS. PMID: 21333341.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    42. Editorial comment. Urology. 2010 Feb; 75(2):398. Smith AB, Pruthi RS, Smith AB, Pruthi RS. PMID: 20152492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results. BJU Int. 2010 Aug; 106(3):349-54. Pruthi RS, Nielsen M, Heathcote S, Wallen EM, Rathmell WK, Godley P, Whang Y, Fielding J, Schultz H, Grigson G, Smith A, Kim W, Pruthi RS, Nielsen M, Heathcote S, Wallen EM, Rathmell WK, Godley P, Whang Y, Fielding J, Schultz H, Grigson G, Smith A, Kim W. PMID: 20089114.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    44. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol. 2010 Feb; 183(2):510-4. Pruthi RS, Nielsen ME, Nix J, Smith A, Schultz H, Wallen EM, Pruthi RS, Nielsen ME, Nix J, Smith A, Schultz H, Wallen EM. PMID: 20006884.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    45. Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients. J Am Coll Surg. 2010 Jan; 210(1):93-9. Pruthi RS, Nielsen M, Smith A, Nix J, Schultz H, Wallen EM, Pruthi RS, Nielsen M, Smith A, Nix J, Schultz H, Wallen EM. PMID: 20123338.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    46. Impact of marital status in patients undergoing radical cystectomy for bladder cancer. World J Urol. 2009 Aug; 27(4):573-6. Pruthi RS, Lentz AC, Sand M, Kouba E, Wallen EM, Pruthi RS, Lentz AC, Sand M, Kouba E, Wallen EM. PMID: 19219612.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    47. Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy. Urology. 2008 Oct; 72(4):864-8. Amin C, Wallen E, Pruthi RS, Calvo BF, Godley PA, Rathmell WK, Amin C, Wallen E, Pruthi RS, Calvo BF, Godley PA, Rathmell WK. PMID: 18684493.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    48. Is robotic radical cystectomy an appropriate treatment for bladder cancer? Short-term oncologic and clinical follow-up in 50 consecutive patients. Urology. 2008 Sep; 72(3):617-20; discussion 620-2. Pruthi RS, Wallen EM, Pruthi RS, Wallen EM. PMID: 18586308.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    49. Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder. Urol Oncol. 2009 Sep-Oct; 27(5):486-90. Kouba EJ, Lentz A, Wallen EM, Pruthi RS, Kouba EJ, Lentz A, Wallen EM, Pruthi RS. PMID: 18555706.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Gum chewing stimulates bowel motility in patients undergoing radical cystectomy with urinary diversion. Urology. 2007 Dec; 70(6):1053-6. Kouba EJ, Wallen EM, Pruthi RS, Kouba EJ, Wallen EM, Pruthi RS. PMID: 18158012.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    51. Conservative management of low risk superficial bladder tumors. J Urol. 2008 Jan; 179(1):87-90; discussion 90. Pruthi RS, Baldwin N, Bhalani V, Wallen EM, Pruthi RS, Baldwin N, Bhalani V, Wallen EM. PMID: 17997444.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    52. Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes. J Urol. 2007 Sep; 178(3 Pt 1):814-8. Pruthi RS, Wallen EM, Pruthi RS, Wallen EM. PMID: 17631334.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    53. Incidence and risk factors of stomal complications in patients undergoing cystectomy with ileal conduit urinary diversion for bladder cancer. J Urol. 2007 Sep; 178(3 Pt 1):950-4. Kouba E, Sands M, Lentz A, Wallen E, Pruthi RS, Kouba E, Sands M, Lentz A, Wallen E, Pruthi RS. PMID: 17632147.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    54. Efficacy and safety of en bloc ligation of renal hilum during laparoscopic nephrectomy. Urology. 2007 Feb; 69(2):226-9. Kouba E, Smith AM, Derksen JE, Gunn K, Wallen E, Pruthi RS, Kouba E, Smith AM, Derksen JE, Gunn K, Wallen E, Pruthi RS. PMID: 17275073.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer. Int Braz J Urol. 2007 Jan-Feb; 33(1):25-31; discussion 31-2. McLaughlin S, Shephard J, Wallen E, Maygarden S, Carson CC, Pruthi RS, McLaughlin S, Shephard J, Wallen E, Maygarden S, Carson CC, Pruthi RS. PMID: 17335595.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    56. Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise? Urology. 2006 Nov; 68(5):917-23. Pruthi RS, Kouba E, Carson CC, Wallen EM, Pruthi RS, Kouba E, Carson CC, Wallen EM. PMID: 17113880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2172-7. Pruthi RS, Derksen JE, Moore D, Carson CC, Grigson G, Watkins C, Wallen E, Pruthi RS, Derksen JE, Moore D, Carson CC, Grigson G, Watkins C, Wallen E. PMID: 16609031.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    58. The use of erythropoietin in patients undergoing radical prostatectomy: effects on hematocrit, transfusion rates and quality of life. Urol Int. 2006; 77(3):211-5. Gaston KE, Kouba E, Moore DT, Pruthi RS, Gaston KE, Kouba E, Moore DT, Pruthi RS. PMID: 17033207.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer. Urology. 2004 Oct; 64(4):637-42. Pruthi RS, Derksen E, Gaston K, Wallen EM, Pruthi RS, Derksen E, Gaston K, Wallen EM. PMID: 15491687.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    60. Value of urinary cytology in the diagnosis and management of urinary tract malignancies. Urology. 2004 Jun; 63(6):1009-16. Gaston KE, Pruthi RS, Gaston KE, Pruthi RS. PMID: 15183936.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Retroperitoneal cyst of the lienorenal ligament. Urology. 2004 Feb; 63(2):379. Richman MN, Molitierno J, Pruthi RS, Richman MN, Molitierno J, Pruthi RS. PMID: 14972498.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Reducing time to oral diet and hospital discharge in patients undergoing radical cystectomy using a perioperative care plan. Urology. 2003 Oct; 62(4):661-5; discussion 665-6. Pruthi RS, Chun J, Richman M, Pruthi RS, Chun J, Richman M. PMID: 14550438.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    63. Overview of bladder cancer trials in the Cancer and Leukemia Group B. Cancer. 2003 Apr 15; 97(8 Suppl):2090-8. Small EJ, Halabi S, Dalbagni G, Pruthi R, Phillips G, Edelman M, Bajorin D, Cancer and Leukemia Group B , Small EJ, Halabi S, Dalbagni G, Pruthi R, Phillips G, Edelman M, Bajorin D, Cancer and Leukemia Group B. PMID: 12673701.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. New onset vesicovaginal fistula after transurethral collagen injection in women who underwent cystectomy and orthotopic neobladder creation: presentation and definitive treatment. J Urol. 2000 Nov; 164(5):1638-9. Pruthi RS, Petrus CD, Bundrick WS JR, Pruthi RS, Petrus CD, Bundrick WS JR. PMID: 11025723.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer. Urology. 1997 May; 49(5):737-42. Pruthi RS, Johnstone I, Tu IP, Stamey TA, Pruthi RS, Johnstone I, Tu IP, Stamey TA. PMID: 9145980.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. New technique of ureteral stent placement for impacted ureteral calculus: the glidewire loop technique. Urology. 1997 Apr; 49(4):614-7. Issa MM, Pruthi RS, McNamara DE, Issa MM, Pruthi RS, McNamara DE. PMID: 9111636.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Use of serum concentration techniques to enhance early detection of recurrent prostate cancer after radical prostatectomy. Urology. 1997 Mar; 49(3):404-10. Pruthi RS, Haese A, Huland E, Stamey TA, Pruthi RS, Haese A, Huland E, Stamey TA. PMID: 9123706.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    Raj's Networks
    Concepts (268)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (35)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-868-g8ba5679c on PROFILES-PWEB01.

    Copyright © The Regents of the University of California